Clinical Trial

Pessary Satisfaction Criteria for Urogenital Prolapse

Study acronym: PeSaCUP
Recruiting
View on ClinicalTrials.gov →
Summary
Genital prolapse is a common pathology with a prevalence ranging from 2.9 to 11.4% or 31.8% to 97.7%, depending on whether a questionnaire or clinical examination is used. The use of pessary in the treatment of prolapse remains discussed despite a satisfaction rate of 50 to 80% in the literature and a minimal complications rate. The main objective of this study is to assess the satisfaction of patients carrying a pessary in the first year after the laying.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2018-08-03; most recent amendment 2024-09-19.
Trial Details
NCT Number NCT03615872
Lead Sponsor University Hospital, Caen
Conditions Genital Prolapse, Pessary, Satisfaction
Enrollment 150 participants
Start Date 2018-06-20
Primary Completion 2018-06-20 (estimated)
Study Completion 2025-06 (estimated)
Updated on ClinicalTrials.gov 2024-09-20